Literature DB >> 3425475

The influence of socioeconomic factors on the occurrence of fetal alcohol syndrome.

N Bingol1, C Schuster, M Fuchs, S Iosub, G Turner, R K Stone, D S Gromisch.   

Abstract

This study was designed to compare manifestations of FAS in the offspring of lower and upper middle class chronic alcoholic mothers, and to compare these offspring with those of nonalcoholic controls. There was highly significant difference in the incidence of FAS offspring between upper middle and lower class alcoholic mothers, 4.5% versus 70.9% respectively. Mean weight, length, and head circumference at birth in children of upper middle class alcoholic women was -ISD, those of lower class alcoholic women fell into -2SD. All other parameters, congenital malformation rate, failure to thrive, mental retardation were also significantly greater in children of lower class alcoholic women (p less than or equal to .01). Attention deficit disorder was found in 21% of upper middle class offspring of alcoholic women as compared to 71% in the children of the lower socioeconomic group (p less than or equal to .01).

Entities:  

Mesh:

Year:  1987        PMID: 3425475     DOI: 10.1300/J251v06n04_08

Source DB:  PubMed          Journal:  Adv Alcohol Subst Abuse        ISSN: 0270-3106


  22 in total

1.  Are We Justified in Introducing Carbon Monoxide Testing to Encourage Smoking Cessation in Pregnant Women?

Authors:  Catherine Bowden
Journal:  Health Care Anal       Date:  2019-06

2.  The Racialized Nature of Child Welfare Policies and the Social Control of Black Bodies.

Authors:  Kathi L H Harp; Amanda M Bunting
Journal:  Soc Polit       Date:  2019-10-23

3.  Fetal alcohol syndrome in Alaska, 1977 through 1992: an administrative prevalence derived from multiple data sources.

Authors:  G M Egeland; K A Perham-Hester; B D Gessner; D Ingle; J E Berner; J P Middaugh
Journal:  Am J Public Health       Date:  1998-05       Impact factor: 9.308

4.  Maternal risk factors predicting child physical characteristics and dysmorphology in fetal alcohol syndrome and partial fetal alcohol syndrome.

Authors:  Philip A May; Barbara G Tabachnick; J Phillip Gossage; Wendy O Kalberg; Anna-Susan Marais; Luther K Robinson; Melanie Manning; David Buckley; H Eugene Hoyme
Journal:  Drug Alcohol Depend       Date:  2011-06-11       Impact factor: 4.492

5.  Complex cardiac defects after ethanol exposure during discrete cardiogenic events in zebrafish: prevention with folic acid.

Authors:  Swapnalee Sarmah; James A Marrs
Journal:  Dev Dyn       Date:  2013-09-02       Impact factor: 3.780

6.  Fetal alcohol syndrome epidemiology in a South African community: a second study of a very high prevalence area.

Authors:  Denis L Viljoen; J Phillip Gossage; Lesley Brooke; Colleen M Adnams; Kenneth L Jones; Luther K Robinson; H Eugene Hoyme; Cudore Snell; Nathaniel C O Khaole; Piyadasa Kodituwakku; Kwadwo Ohene Asante; Richard Findlay; Barbara Quinton; Anna-Susan Marais; Wendy O Kalberg; Philip A May
Journal:  J Stud Alcohol       Date:  2005-09

7.  Maternal risk factors for fetal alcohol syndrome in the Western cape province of South Africa: a population-based study.

Authors:  Philip A May; J Phillip Gossage; Lesley E Brooke; Cudore L Snell; Anna-Susan Marais; Loretta S Hendricks; Julie A Croxford; Denis L Viljoen
Journal:  Am J Public Health       Date:  2005-06-02       Impact factor: 9.308

8.  Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis.

Authors:  Albert E Chudley; Julianne Conry; Jocelynn L Cook; Christine Loock; Ted Rosales; Nicole LeBlanc
Journal:  CMAJ       Date:  2005-03-01       Impact factor: 8.262

9.  Epidemiology of fetal alcohol syndrome in a South African community in the Western Cape Province.

Authors:  P A May; L Brooke; J P Gossage; J Croxford; C Adnams; K L Jones; L Robinson; D Viljoen
Journal:  Am J Public Health       Date:  2000-12       Impact factor: 9.308

10.  Surveillance for fetal alcohol syndrome in Colorado.

Authors:  L A Miller; T Shaikh; C Stanton; A Montgomery; R Rickard; S Keefer; R Hoffman
Journal:  Public Health Rep       Date:  1995 Nov-Dec       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.